Biomarker analyses in the phase III ASCENT study of sacituzumab govitecan versus chemotherapy in patients with metastatic triple-negative breast cancer

P. Aftimos, L. Vahdat, V. Diéras, J. O apos Shaughnessy, M. Oliveira, T. Traina, MF Tsai, S.M. Tolaney, D. Loirat, M. Olivo, K. Punie, E.C. Gil, S.A. Hurvitz, Q. Hong, P. Sharma, S. Sardesai, S. Recalde, A. Bardia, F. Dalenc, K. Kalinsky, A. Zelnak, L.M. Itri, Júlia Alves Côrtes, E. Hamilton, L.A. Carey, H.S. Rugo, D.M. Goldenberg